

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.40746854 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.00804622 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.00804622 |
| 4 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 5.89014835 |
| 5 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.56237486 |
| 6 | respiratory electron transport chain (GO:0022904) | 5.23293824 |
| 7 | electron transport chain (GO:0022900) | 5.11719383 |
| 8 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.77004426 |
| 9 | negative regulation of ligase activity (GO:0051352) | 4.77004426 |
| 10 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.71482886 |
| 11 | signal peptide processing (GO:0006465) | 4.62998219 |
| 12 | protein complex biogenesis (GO:0070271) | 4.57001831 |
| 13 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.53389354 |
| 14 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.37051433 |
| 15 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.31919261 |
| 16 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.20438403 |
| 17 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.17594229 |
| 18 | NADH dehydrogenase complex assembly (GO:0010257) | 4.17594229 |
| 19 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.17594229 |
| 20 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.11504125 |
| 21 | chaperone-mediated protein transport (GO:0072321) | 4.00633488 |
| 22 | aldehyde catabolic process (GO:0046185) | 4.00560771 |
| 23 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.98980683 |
| 24 | positive regulation of ligase activity (GO:0051351) | 3.93384399 |
| 25 | rRNA modification (GO:0000154) | 3.93032377 |
| 26 | protein neddylation (GO:0045116) | 3.90748263 |
| 27 | fatty acid elongation (GO:0030497) | 3.86391429 |
| 28 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.70100108 |
| 29 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.70100108 |
| 30 | respiratory chain complex IV assembly (GO:0008535) | 3.69981458 |
| 31 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.68171691 |
| 32 | L-phenylalanine catabolic process (GO:0006559) | 3.67767724 |
| 33 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.67767724 |
| 34 | proteasome assembly (GO:0043248) | 3.60421604 |
| 35 | regulation of ligase activity (GO:0051340) | 3.54786337 |
| 36 | positive regulation of cell cycle arrest (GO:0071158) | 3.54396790 |
| 37 | L-phenylalanine metabolic process (GO:0006558) | 3.50375099 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.50375099 |
| 39 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.46348147 |
| 40 | cytochrome complex assembly (GO:0017004) | 3.45698286 |
| 41 | regulation of mitochondrial translation (GO:0070129) | 3.43863175 |
| 42 | GTP biosynthetic process (GO:0006183) | 3.43062764 |
| 43 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.41232218 |
| 44 | negative regulation of protein ubiquitination (GO:0031397) | 3.39885922 |
| 45 | cytidine metabolic process (GO:0046087) | 3.37674749 |
| 46 | cytidine catabolic process (GO:0006216) | 3.37674749 |
| 47 | cytidine deamination (GO:0009972) | 3.37674749 |
| 48 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.27900380 |
| 49 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.27531880 |
| 50 | hydrogen ion transmembrane transport (GO:1902600) | 3.27260056 |
| 51 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.23467505 |
| 52 | platelet dense granule organization (GO:0060155) | 3.22646793 |
| 53 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 3.22421184 |
| 54 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.21174513 |
| 55 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.20007011 |
| 56 | ATP biosynthetic process (GO:0006754) | 3.17868859 |
| 57 | cholesterol biosynthetic process (GO:0006695) | 3.16829193 |
| 58 | rRNA methylation (GO:0031167) | 3.13469571 |
| 59 | regulation of metalloenzyme activity (GO:0048552) | 3.13078705 |
| 60 | ribosomal small subunit biogenesis (GO:0042274) | 3.11697668 |
| 61 | GDP-mannose metabolic process (GO:0019673) | 3.10741067 |
| 62 | nucleotide transmembrane transport (GO:1901679) | 3.09454205 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.07087174 |
| 64 | base-excision repair, AP site formation (GO:0006285) | 3.06003561 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 3.03940881 |
| 66 | proton transport (GO:0015992) | 3.02890891 |
| 67 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.01182140 |
| 68 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.00006381 |
| 69 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.98815945 |
| 70 | hydrogen transport (GO:0006818) | 2.98502973 |
| 71 | regulation of cell cycle arrest (GO:0071156) | 2.98167215 |
| 72 | pseudouridine synthesis (GO:0001522) | 2.95547618 |
| 73 | inner mitochondrial membrane organization (GO:0007007) | 2.95060937 |
| 74 | signal transduction in response to DNA damage (GO:0042770) | 2.94636383 |
| 75 | cofactor catabolic process (GO:0051187) | 2.93886568 |
| 76 | aromatic amino acid family catabolic process (GO:0009074) | 2.91032995 |
| 77 | amino acid salvage (GO:0043102) | 2.89780819 |
| 78 | L-methionine salvage (GO:0071267) | 2.89780819 |
| 79 | L-methionine biosynthetic process (GO:0071265) | 2.89780819 |
| 80 | ribosomal small subunit assembly (GO:0000028) | 2.88025453 |
| 81 | negative regulation of cell cycle G1/S phase transition (GO:1902807) | 2.86714498 |
| 82 | negative regulation of G1/S transition of mitotic cell cycle (GO:2000134) | 2.86714498 |
| 83 | cellular response to zinc ion (GO:0071294) | 2.86486487 |
| 84 | mitochondrial transport (GO:0006839) | 2.85460226 |
| 85 | translation (GO:0006412) | 2.84829632 |
| 86 | basic amino acid transport (GO:0015802) | 2.84748440 |
| 87 | sterol biosynthetic process (GO:0016126) | 2.84483685 |
| 88 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.84397328 |
| 89 | regulation of oxidative phosphorylation (GO:0002082) | 2.81724671 |
| 90 | neutrophil activation involved in immune response (GO:0002283) | 2.81672363 |
| 91 | peptidyl-histidine modification (GO:0018202) | 2.81378716 |
| 92 | iron-sulfur cluster assembly (GO:0016226) | 2.80812910 |
| 93 | metallo-sulfur cluster assembly (GO:0031163) | 2.80812910 |
| 94 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.77764310 |
| 95 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.76891240 |
| 96 | C-terminal protein lipidation (GO:0006501) | 2.76832996 |
| 97 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.76233362 |
| 98 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.75728222 |
| 99 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.75728222 |
| 100 | oxidative phosphorylation (GO:0006119) | 2.74432102 |
| 101 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.72562504 |
| 102 | termination of RNA polymerase III transcription (GO:0006386) | 2.72562504 |
| 103 | removal of superoxide radicals (GO:0019430) | 2.70442535 |
| 104 | cellular response to superoxide (GO:0071451) | 2.70442535 |
| 105 | cellular response to oxygen radical (GO:0071450) | 2.70442535 |
| 106 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.69369851 |
| 107 | DNA deamination (GO:0045006) | 2.68606487 |
| 108 | protein-cofactor linkage (GO:0018065) | 2.64167468 |
| 109 | mannosylation (GO:0097502) | 2.64145354 |
| 110 | central nervous system myelination (GO:0022010) | 2.64086932 |
| 111 | axon ensheathment in central nervous system (GO:0032291) | 2.64086932 |
| 112 | ketone body metabolic process (GO:1902224) | 2.60860214 |
| 113 | regulation of cellular amine metabolic process (GO:0033238) | 2.60843516 |
| 114 | UTP biosynthetic process (GO:0006228) | 2.60489439 |
| 115 | protein targeting to mitochondrion (GO:0006626) | 2.59613075 |
| 116 | GPI anchor biosynthetic process (GO:0006506) | 2.55178740 |
| 117 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.54353784 |
| 118 | establishment of protein localization to mitochondrion (GO:0072655) | 2.54276623 |
| 119 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.49686634 |
| 120 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.48240249 |
| 121 | mitochondrion morphogenesis (GO:0070584) | 2.48044202 |
| 122 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.48009805 |
| 123 | positive regulation of protein homodimerization activity (GO:0090073) | 2.45128803 |
| 124 | dopamine transport (GO:0015872) | 2.44086745 |
| 125 | UTP metabolic process (GO:0046051) | 2.43376210 |
| 126 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.42503352 |
| 127 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.42503352 |
| 128 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.42503352 |
| 129 | isoprenoid biosynthetic process (GO:0008299) | 2.42397034 |
| 130 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.42382574 |
| 131 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42382574 |
| 132 | response to redox state (GO:0051775) | 2.39333199 |
| 133 | cullin deneddylation (GO:0010388) | 2.39178679 |
| 134 | aerobic respiration (GO:0009060) | 2.37755696 |
| 135 | CTP metabolic process (GO:0046036) | 2.37717803 |
| 136 | CTP biosynthetic process (GO:0006241) | 2.37717803 |
| 137 | protein deneddylation (GO:0000338) | 2.37257588 |
| 138 | coenzyme catabolic process (GO:0009109) | 2.36734359 |
| 139 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.36533899 |
| 140 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.35026770 |
| 141 | intracellular protein transmembrane import (GO:0044743) | 2.34613055 |
| 142 | aromatic amino acid family metabolic process (GO:0009072) | 2.33345455 |
| 143 | protein localization to mitochondrion (GO:0070585) | 2.32608220 |
| 144 | positive regulation of mitochondrial fission (GO:0090141) | 2.32438820 |
| 145 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.31858296 |
| 146 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.31858296 |
| 147 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.31087219 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.75486955 |
| 2 | * KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.54931865 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.43890067 |
| 4 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.27644666 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.27050375 |
| 6 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 3.24458029 |
| 7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.00292402 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.00279342 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.94031762 |
| 10 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.65892029 |
| 11 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.63764009 |
| 12 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.57407979 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.55817922 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.55321617 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.54170156 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.42130241 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.41633943 |
| 18 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.22725562 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.21360866 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.15454487 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.10322581 |
| 22 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06112639 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.98737828 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.96663904 |
| 25 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89516328 |
| 26 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.87996098 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.84576495 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.81815408 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.74789511 |
| 30 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.74220861 |
| 31 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.72344227 |
| 32 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.68315672 |
| 33 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.68287541 |
| 34 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.64218507 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.61043200 |
| 36 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.56222858 |
| 37 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.55374053 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.55316097 |
| 39 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.50120809 |
| 40 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.49291855 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44568632 |
| 42 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.41515583 |
| 43 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40690529 |
| 44 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.37943152 |
| 45 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.37902918 |
| 46 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35269025 |
| 47 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.32286438 |
| 48 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32280360 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.31716024 |
| 50 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.31466233 |
| 51 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.31285035 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.29337641 |
| 53 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.29113245 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.28952560 |
| 55 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.27964104 |
| 56 | * PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.26976453 |
| 57 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26619872 |
| 58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26326022 |
| 59 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.25719115 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.25571249 |
| 61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.25497949 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.24757084 |
| 63 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.22609974 |
| 64 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.21600469 |
| 65 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.20318882 |
| 66 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.17979945 |
| 67 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.17973316 |
| 68 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.17576510 |
| 69 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16295789 |
| 70 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.15717441 |
| 71 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15422599 |
| 72 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13758748 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13329297 |
| 74 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.13083874 |
| 75 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12358802 |
| 76 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.11765817 |
| 77 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.11590413 |
| 78 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.11029046 |
| 79 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.10994274 |
| 80 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.10724973 |
| 81 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.10496578 |
| 82 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09770258 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09215185 |
| 84 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.08364407 |
| 85 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.05648522 |
| 86 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.03752307 |
| 87 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.03000790 |
| 88 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02583223 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02473300 |
| 90 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01852462 |
| 91 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00775708 |
| 92 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.99869717 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.99739115 |
| 94 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.98973994 |
| 95 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.97484583 |
| 96 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97380601 |
| 97 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.97342856 |
| 98 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97338957 |
| 99 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.97280327 |
| 100 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.96308339 |
| 101 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96287895 |
| 102 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.95594022 |
| 103 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95083784 |
| 104 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94887933 |
| 105 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.93779263 |
| 106 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.93575225 |
| 107 | AR_20517297_ChIP-Seq_VCAP_Human | 0.93458175 |
| 108 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.93169842 |
| 109 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.91863061 |
| 110 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.90823441 |
| 111 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.90604749 |
| 112 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.90524749 |
| 113 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.89969413 |
| 114 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89731060 |
| 115 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.88477309 |
| 116 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.88434132 |
| 117 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.88337726 |
| 118 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.88192045 |
| 119 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87883616 |
| 120 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.87743461 |
| 121 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.86250002 |
| 122 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85400681 |
| 123 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.85365527 |
| 124 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.85277167 |
| 125 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.84570252 |
| 126 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84353208 |
| 127 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.84072054 |
| 128 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.83987580 |
| 129 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.82706038 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82444129 |
| 131 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.82008604 |
| 132 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.81803848 |
| 133 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.81711041 |
| 134 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.81711041 |
| 135 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.79872537 |
| 136 | ERA_21632823_ChIP-Seq_H3396_Human | 0.79535764 |
| 137 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79011039 |
| 138 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78502112 |
| 139 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.78146888 |
| 140 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.78082548 |
| 141 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.78082548 |
| 142 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.76575220 |
| 143 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.76556603 |
| 144 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.75935223 |
| 145 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.75607268 |
| 146 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.75451178 |
| 147 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.75401508 |
| 148 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.74888026 |
| 149 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.73476486 |
| 150 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.73013847 |
| 151 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.72715459 |
| 152 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.72648331 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.07841798 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.41828152 |
| 3 | MP0003195_calcinosis | 3.00963176 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 2.75037359 |
| 5 | MP0003880_abnormal_central_pattern | 2.73177154 |
| 6 | MP0001529_abnormal_vocalization | 2.56423103 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.54044701 |
| 8 | MP0003186_abnormal_redox_activity | 2.44977053 |
| 9 | MP0002254_reproductive_system_inflammat | 2.43877521 |
| 10 | MP0001905_abnormal_dopamine_level | 2.43492186 |
| 11 | MP0005365_abnormal_bile_salt | 2.42544302 |
| 12 | MP0005083_abnormal_biliary_tract | 2.37351916 |
| 13 | MP0005084_abnormal_gallbladder_morpholo | 2.37341785 |
| 14 | MP0006054_spinal_hemorrhage | 2.31877342 |
| 15 | MP0003136_yellow_coat_color | 2.23822284 |
| 16 | MP0008058_abnormal_DNA_repair | 2.21454410 |
| 17 | MP0005360_urolithiasis | 2.14609124 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.12502980 |
| 19 | MP0002876_abnormal_thyroid_physiology | 2.11753119 |
| 20 | MP0003786_premature_aging | 2.10716907 |
| 21 | MP0009785_altered_susceptibility_to | 2.07669949 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.01141292 |
| 23 | MP0003724_increased_susceptibility_to | 2.00479960 |
| 24 | MP0006276_abnormal_autonomic_nervous | 1.96178498 |
| 25 | MP0004043_abnormal_pH_regulation | 1.95700113 |
| 26 | MP0002736_abnormal_nociception_after | 1.92109759 |
| 27 | MP0009697_abnormal_copulation | 1.90609013 |
| 28 | MP0005379_endocrine/exocrine_gland_phen | 1.87384443 |
| 29 | MP0001727_abnormal_embryo_implantation | 1.87373607 |
| 30 | MP0000749_muscle_degeneration | 1.86400921 |
| 31 | MP0001986_abnormal_taste_sensitivity | 1.84712354 |
| 32 | MP0005058_abnormal_lysosome_morphology | 1.83802270 |
| 33 | MP0010386_abnormal_urinary_bladder | 1.81894836 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.79695906 |
| 35 | MP0005075_abnormal_melanosome_morpholog | 1.79125329 |
| 36 | MP0001764_abnormal_homeostasis | 1.75065844 |
| 37 | MP0005332_abnormal_amino_acid | 1.74535989 |
| 38 | MP0001853_heart_inflammation | 1.65650312 |
| 39 | MP0002638_abnormal_pupillary_reflex | 1.63005646 |
| 40 | MP0005636_abnormal_mineral_homeostasis | 1.62402135 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 1.60913846 |
| 42 | MP0000343_altered_response_to | 1.60007763 |
| 43 | MP0009333_abnormal_splenocyte_physiolog | 1.59659968 |
| 44 | MP0004142_abnormal_muscle_tone | 1.59191341 |
| 45 | MP0003011_delayed_dark_adaptation | 1.58459377 |
| 46 | MP0001542_abnormal_bone_strength | 1.56502512 |
| 47 | MP0003693_abnormal_embryo_hatching | 1.51922782 |
| 48 | MP0008004_abnormal_stomach_pH | 1.48662188 |
| 49 | MP0001968_abnormal_touch/_nociception | 1.47442876 |
| 50 | MP0000566_synostosis | 1.46326804 |
| 51 | MP0005671_abnormal_response_to | 1.44544740 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.42527906 |
| 53 | MP0002148_abnormal_hypersensitivity_rea | 1.42183206 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.39435246 |
| 55 | MP0002138_abnormal_hepatobiliary_system | 1.38483705 |
| 56 | MP0003656_abnormal_erythrocyte_physiolo | 1.35700828 |
| 57 | MP0005410_abnormal_fertilization | 1.33936363 |
| 58 | MP0002735_abnormal_chemical_nociception | 1.32934935 |
| 59 | MP0002102_abnormal_ear_morphology | 1.32391424 |
| 60 | MP0008007_abnormal_cellular_replicative | 1.32202554 |
| 61 | MP0002132_abnormal_respiratory_system | 1.30958999 |
| 62 | MP0000358_abnormal_cell_content/ | 1.27293578 |
| 63 | MP0002090_abnormal_vision | 1.26794180 |
| 64 | MP0004957_abnormal_blastocyst_morpholog | 1.25820997 |
| 65 | MP0002163_abnormal_gland_morphology | 1.25139660 |
| 66 | MP0000920_abnormal_myelination | 1.24911742 |
| 67 | MP0002723_abnormal_immune_serum | 1.19758871 |
| 68 | MP0001919_abnormal_reproductive_system | 1.17243014 |
| 69 | MP0003077_abnormal_cell_cycle | 1.16000286 |
| 70 | MP0002837_dystrophic_cardiac_calcinosis | 1.15903998 |
| 71 | MP0002452_abnormal_antigen_presenting | 1.15889631 |
| 72 | MP0000685_abnormal_immune_system | 1.15392298 |
| 73 | MP0003315_abnormal_perineum_morphology | 1.15373932 |
| 74 | MP0003191_abnormal_cellular_cholesterol | 1.15184099 |
| 75 | MP0008260_abnormal_autophagy | 1.12909867 |
| 76 | MP0001845_abnormal_inflammatory_respons | 1.10891761 |
| 77 | MP0009643_abnormal_urine_homeostasis | 1.10630681 |
| 78 | MP0005551_abnormal_eye_electrophysiolog | 1.10616092 |
| 79 | MP0008877_abnormal_DNA_methylation | 1.09454887 |
| 80 | MP0006035_abnormal_mitochondrial_morpho | 1.08531503 |
| 81 | MP0008469_abnormal_protein_level | 1.08089789 |
| 82 | MP0002272_abnormal_nervous_system | 1.07442033 |
| 83 | MP0004019_abnormal_vitamin_homeostasis | 1.07185506 |
| 84 | MP0006082_CNS_inflammation | 1.07170008 |
| 85 | MP0001501_abnormal_sleep_pattern | 1.05753129 |
| 86 | MP0000372_irregular_coat_pigmentation | 1.04721703 |
| 87 | MP0001800_abnormal_humoral_immune | 1.04238946 |
| 88 | MP0002933_joint_inflammation | 1.03495952 |
| 89 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.03491224 |
| 90 | MP0000015_abnormal_ear_pigmentation | 1.02944352 |
| 91 | MP0008873_increased_physiological_sensi | 1.02023603 |
| 92 | MP0009764_decreased_sensitivity_to | 1.01941987 |
| 93 | MP0005535_abnormal_body_temperature | 1.01840067 |
| 94 | MP0001664_abnormal_digestion | 1.01481616 |
| 95 | MP0005025_abnormal_response_to | 1.01410442 |
| 96 | MP0005408_hypopigmentation | 1.01272089 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 1.00602911 |
| 98 | MP0002420_abnormal_adaptive_immunity | 0.99659339 |
| 99 | MP0005000_abnormal_immune_tolerance | 0.99519937 |
| 100 | MP0004145_abnormal_muscle_electrophysio | 0.97930946 |
| 101 | MP0000538_abnormal_urinary_bladder | 0.97434620 |
| 102 | MP0002734_abnormal_mechanical_nocicepti | 0.97317076 |
| 103 | MP0003868_abnormal_feces_composition | 0.96705742 |
| 104 | MP0000750_abnormal_muscle_regeneration | 0.96389077 |
| 105 | MP0001819_abnormal_immune_cell | 0.96311075 |
| 106 | MP0002419_abnormal_innate_immunity | 0.95706361 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.94640155 |
| 108 | MP0010094_abnormal_chromosome_stability | 0.94204269 |
| 109 | MP0003075_altered_response_to | 0.93520647 |
| 110 | MP0001440_abnormal_grooming_behavior | 0.92954380 |
| 111 | MP0005253_abnormal_eye_physiology | 0.90640681 |
| 112 | MP0001835_abnormal_antigen_presentation | 0.90485031 |
| 113 | MP0004381_abnormal_hair_follicle | 0.89435728 |
| 114 | MP0001790_abnormal_immune_system | 0.89317691 |
| 115 | MP0005387_immune_system_phenotype | 0.89317691 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.89040671 |
| 117 | MP0002938_white_spotting | 0.88932746 |
| 118 | MP0002295_abnormal_pulmonary_circulatio | 0.87202867 |
| 119 | MP0005646_abnormal_pituitary_gland | 0.86668459 |
| 120 | MP0001984_abnormal_olfaction | 0.86290882 |
| 121 | MP0008789_abnormal_olfactory_epithelium | 0.86226286 |
| 122 | MP0005389_reproductive_system_phenotype | 0.85975307 |
| 123 | MP0004147_increased_porphyrin_level | 0.85690590 |
| 124 | MP0003436_decreased_susceptibility_to | 0.85646481 |
| 125 | MP0002822_catalepsy | 0.84922481 |
| 126 | MP0008872_abnormal_physiological_respon | 0.84415068 |
| 127 | MP0005367_renal/urinary_system_phenotyp | 0.83773943 |
| 128 | MP0000516_abnormal_urinary_system | 0.83773943 |
| 129 | MP0003111_abnormal_nucleus_morphology | 0.83261850 |
| 130 | MP0008995_early_reproductive_senescence | 0.82746656 |
| 131 | MP0001485_abnormal_pinna_reflex | 0.82257973 |
| 132 | MP0008932_abnormal_embryonic_tissue | 0.81958691 |
| 133 | MP0009840_abnormal_foam_cell | 0.81695643 |
| 134 | MP0003959_abnormal_lean_body | 0.81248887 |
| 135 | MP0005330_cardiomyopathy | 0.80126518 |
| 136 | MP0000604_amyloidosis | 0.79570808 |
| 137 | MP0001188_hyperpigmentation | 0.78525479 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.78243774 |
| 139 | MP0003137_abnormal_impulse_conducting | 0.78159151 |
| 140 | MP0003718_maternal_effect | 0.78098266 |
| 141 | MP0005451_abnormal_body_composition | 0.77902712 |
| 142 | MP0010329_abnormal_lipoprotein_level | 0.77843771 |
| 143 | MP0001970_abnormal_pain_threshold | 0.76806776 |
| 144 | MP0009745_abnormal_behavioral_response | 0.76741680 |
| 145 | MP0005171_absent_coat_pigmentation | 0.75858574 |
| 146 | MP0005376_homeostasis/metabolism_phenot | 0.74782747 |
| 147 | MP0005645_abnormal_hypothalamus_physiol | 0.73647143 |
| 148 | MP0004924_abnormal_behavior | 0.73456424 |
| 149 | MP0005386_behavior/neurological_phenoty | 0.73456424 |
| 150 | MP0002160_abnormal_reproductive_system | 0.73427152 |
| 151 | MP0002405_respiratory_system_inflammati | 0.72262679 |
| 152 | MP0005381_digestive/alimentary_phenotyp | 0.71576549 |
| 153 | MP0002064_seizures | 0.71377984 |
| 154 | MP0002095_abnormal_skin_pigmentation | 0.70657565 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 6.26580425 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.72599115 |
| 3 | Acute encephalopathy (HP:0006846) | 5.43357732 |
| 4 | Mitochondrial inheritance (HP:0001427) | 5.30189009 |
| 5 | Progressive macrocephaly (HP:0004481) | 5.04625953 |
| 6 | Increased CSF lactate (HP:0002490) | 4.46145468 |
| 7 | Hepatocellular necrosis (HP:0001404) | 4.36089616 |
| 8 | Agnosia (HP:0010524) | 4.28408156 |
| 9 | Hepatic necrosis (HP:0002605) | 4.13106195 |
| 10 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 4.12303319 |
| 11 | Cerebral edema (HP:0002181) | 4.05768269 |
| 12 | Renal Fanconi syndrome (HP:0001994) | 3.95752290 |
| 13 | Increased hepatocellular lipid droplets (HP:0006565) | 3.91328382 |
| 14 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.78171473 |
| 15 | 3-Methylglutaconic aciduria (HP:0003535) | 3.75111951 |
| 16 | Lipid accumulation in hepatocytes (HP:0006561) | 3.72067980 |
| 17 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.60905757 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.35147401 |
| 19 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.32594311 |
| 20 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.32594311 |
| 21 | Optic disc pallor (HP:0000543) | 3.22942929 |
| 22 | Lactic acidosis (HP:0003128) | 3.18911715 |
| 23 | Increased intramyocellular lipid droplets (HP:0012240) | 3.18649828 |
| 24 | Exercise intolerance (HP:0003546) | 3.17737951 |
| 25 | Leukodystrophy (HP:0002415) | 3.07307914 |
| 26 | Respiratory failure (HP:0002878) | 3.06406366 |
| 27 | Increased serum pyruvate (HP:0003542) | 2.97523489 |
| 28 | Abnormality of glycolysis (HP:0004366) | 2.97523489 |
| 29 | Axonal loss (HP:0003447) | 2.97518995 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.89487670 |
| 31 | Disinhibition (HP:0000734) | 2.89268582 |
| 32 | Increased serum lactate (HP:0002151) | 2.87717936 |
| 33 | Exertional dyspnea (HP:0002875) | 2.75560419 |
| 34 | Lethargy (HP:0001254) | 2.74401026 |
| 35 | Abnormality of renal resorption (HP:0011038) | 2.73531357 |
| 36 | Aplastic anemia (HP:0001915) | 2.71326622 |
| 37 | Prolonged partial thromboplastin time (HP:0003645) | 2.68049414 |
| 38 | Hypothermia (HP:0002045) | 2.63655273 |
| 39 | Amniotic constriction ring (HP:0009775) | 2.58811221 |
| 40 | Abnormality of placental membranes (HP:0011409) | 2.58811221 |
| 41 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.55606054 |
| 42 | Abnormal tarsal ossification (HP:0008369) | 2.50661132 |
| 43 | Neuroendocrine neoplasm (HP:0100634) | 2.49741280 |
| 44 | Methylmalonic acidemia (HP:0002912) | 2.48077404 |
| 45 | Abnormality of urine glucose concentration (HP:0011016) | 2.47865011 |
| 46 | Glycosuria (HP:0003076) | 2.47865011 |
| 47 | IgM deficiency (HP:0002850) | 2.43715024 |
| 48 | Hyperphosphaturia (HP:0003109) | 2.39241074 |
| 49 | Methylmalonic aciduria (HP:0012120) | 2.37112679 |
| 50 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.23814906 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.20431110 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.20431110 |
| 53 | Hyperalaninemia (HP:0003348) | 2.20431110 |
| 54 | Abnormality of methionine metabolism (HP:0010901) | 2.19391458 |
| 55 | Poor head control (HP:0002421) | 2.19007151 |
| 56 | Parakeratosis (HP:0001036) | 2.17719739 |
| 57 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.17053653 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.13112049 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13112049 |
| 60 | Type I transferrin isoform profile (HP:0003642) | 2.11386198 |
| 61 | Degeneration of anterior horn cells (HP:0002398) | 2.09432845 |
| 62 | Abnormality of the anterior horn cell (HP:0006802) | 2.09432845 |
| 63 | Vomiting (HP:0002013) | 2.09299050 |
| 64 | CNS demyelination (HP:0007305) | 2.08491103 |
| 65 | Hypobetalipoproteinemia (HP:0003563) | 2.07303883 |
| 66 | Upper motor neuron abnormality (HP:0002127) | 2.06035214 |
| 67 | Progressive external ophthalmoplegia (HP:0000590) | 2.04829851 |
| 68 | Pheochromocytoma (HP:0002666) | 2.04168774 |
| 69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.03688975 |
| 70 | Gliosis (HP:0002171) | 2.02001370 |
| 71 | Intrahepatic cholestasis (HP:0001406) | 2.00428402 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 1.99571144 |
| 73 | Stomatitis (HP:0010280) | 1.97680490 |
| 74 | Pancytopenia (HP:0001876) | 1.97421188 |
| 75 | Personality changes (HP:0000751) | 1.97409349 |
| 76 | Abnormal urine phosphate concentration (HP:0012599) | 1.97051771 |
| 77 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 1.96972978 |
| 78 | X-linked dominant inheritance (HP:0001423) | 1.96032417 |
| 79 | Testicular atrophy (HP:0000029) | 1.91516774 |
| 80 | Generalized aminoaciduria (HP:0002909) | 1.91502893 |
| 81 | Renal cortical cysts (HP:0000803) | 1.91440871 |
| 82 | Respiratory difficulties (HP:0002880) | 1.90721681 |
| 83 | Progressive microcephaly (HP:0000253) | 1.90526975 |
| 84 | Nausea (HP:0002018) | 1.88666329 |
| 85 | Ileus (HP:0002595) | 1.87540790 |
| 86 | Polyphagia (HP:0002591) | 1.87385557 |
| 87 | IgG deficiency (HP:0004315) | 1.86535892 |
| 88 | Oral leukoplakia (HP:0002745) | 1.86325259 |
| 89 | Absent thumb (HP:0009777) | 1.85997835 |
| 90 | Recurrent bacterial skin infections (HP:0005406) | 1.85053521 |
| 91 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.81331295 |
| 92 | Reduced antithrombin III activity (HP:0001976) | 1.80770835 |
| 93 | Hypoplasia of the uterus (HP:0000013) | 1.80552438 |
| 94 | Abnormal number of erythroid precursors (HP:0012131) | 1.80545644 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79841131 |
| 96 | Hypoglycemic coma (HP:0001325) | 1.79810533 |
| 97 | Fat malabsorption (HP:0002630) | 1.79782179 |
| 98 | Vacuolated lymphocytes (HP:0001922) | 1.79452304 |
| 99 | Increased IgM level (HP:0003496) | 1.78232305 |
| 100 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.77912999 |
| 101 | Emotional lability (HP:0000712) | 1.77894349 |
| 102 | Opisthotonus (HP:0002179) | 1.75420871 |
| 103 | Rough bone trabeculation (HP:0100670) | 1.75054658 |
| 104 | Poor suck (HP:0002033) | 1.73954657 |
| 105 | Abnormal pupillary function (HP:0007686) | 1.73824839 |
| 106 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.73557399 |
| 107 | Steatorrhea (HP:0002570) | 1.72669699 |
| 108 | Microvesicular hepatic steatosis (HP:0001414) | 1.72548944 |
| 109 | Abnormality of the motor neurons (HP:0002450) | 1.72544084 |
| 110 | Abnormal neuron morphology (HP:0012757) | 1.72544084 |
| 111 | Irregular vertebral endplates (HP:0003301) | 1.69550308 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68608008 |
| 113 | Renal tubular dysfunction (HP:0000124) | 1.68343335 |
| 114 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.67758859 |
| 115 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.67758859 |
| 116 | Abnormality of glycolipid metabolism (HP:0010969) | 1.67758859 |
| 117 | Microretrognathia (HP:0000308) | 1.67632501 |
| 118 | Congenital, generalized hypertrichosis (HP:0004540) | 1.65933249 |
| 119 | Pustule (HP:0200039) | 1.65402304 |
| 120 | Proximal tubulopathy (HP:0000114) | 1.65029208 |
| 121 | Inappropriate behavior (HP:0000719) | 1.64675507 |
| 122 | Bone cyst (HP:0012062) | 1.64559893 |
| 123 | Type 2 muscle fiber atrophy (HP:0003554) | 1.64338298 |
| 124 | Recurrent abscess formation (HP:0002722) | 1.64067434 |
| 125 | Neck muscle weakness (HP:0000467) | 1.64054365 |
| 126 | Chronic bronchitis (HP:0004469) | 1.63028519 |
| 127 | Congenital sensorineural hearing impairment (HP:0008527) | 1.62526502 |
| 128 | Hypophosphatemic rickets (HP:0004912) | 1.61906302 |
| 129 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.61574854 |
| 130 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.61574854 |
| 131 | Abnormal protein glycosylation (HP:0012346) | 1.61574854 |
| 132 | Abnormal glycosylation (HP:0012345) | 1.61574854 |
| 133 | Prolonged neonatal jaundice (HP:0006579) | 1.60090852 |
| 134 | Enlarged kidneys (HP:0000105) | 1.59701212 |
| 135 | Metabolic acidosis (HP:0001942) | 1.57725808 |
| 136 | Brushfield spots (HP:0001088) | 1.57207330 |
| 137 | Hyperventilation (HP:0002883) | 1.56886028 |
| 138 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.56383351 |
| 139 | Cerebral hypomyelination (HP:0006808) | 1.55028329 |
| 140 | True hermaphroditism (HP:0010459) | 1.53838904 |
| 141 | Abnormal hemoglobin (HP:0011902) | 1.53707711 |
| 142 | Abnormal gallbladder physiology (HP:0012438) | 1.52230849 |
| 143 | Cholecystitis (HP:0001082) | 1.52230849 |
| 144 | Xanthomatosis (HP:0000991) | 1.51994911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK16 | 3.66550129 |
| 2 | VRK2 | 3.61804066 |
| 3 | PBK | 3.41530207 |
| 4 | PDK2 | 2.37558306 |
| 5 | NME2 | 2.35976157 |
| 6 | EIF2AK3 | 2.33144426 |
| 7 | NME1 | 2.32861487 |
| 8 | BUB1 | 2.22151631 |
| 9 | CASK | 2.16448311 |
| 10 | BCKDK | 2.15164643 |
| 11 | MAPK15 | 2.12658895 |
| 12 | STK39 | 2.02907191 |
| 13 | PINK1 | 2.02672948 |
| 14 | TESK2 | 1.85882964 |
| 15 | EIF2AK1 | 1.84923564 |
| 16 | MST4 | 1.80967583 |
| 17 | MAPKAPK5 | 1.73630587 |
| 18 | NEK1 | 1.71500380 |
| 19 | IRAK3 | 1.69601419 |
| 20 | MAP4K2 | 1.67175045 |
| 21 | BMPR1B | 1.66625119 |
| 22 | BCR | 1.66130223 |
| 23 | IRAK4 | 1.64438281 |
| 24 | PIK3CG | 1.61817863 |
| 25 | MARK3 | 1.56709017 |
| 26 | TXK | 1.54311291 |
| 27 | VRK1 | 1.50668766 |
| 28 | ADRBK2 | 1.49640708 |
| 29 | KDR | 1.48975199 |
| 30 | TRIM28 | 1.48277314 |
| 31 | INSRR | 1.46445981 |
| 32 | OXSR1 | 1.45446123 |
| 33 | MYLK | 1.45340667 |
| 34 | MAP3K11 | 1.41169089 |
| 35 | CSNK1G1 | 1.38363992 |
| 36 | BMPR2 | 1.37765170 |
| 37 | WNK4 | 1.36908211 |
| 38 | MAP3K12 | 1.35033181 |
| 39 | CSNK1A1L | 1.34320160 |
| 40 | PIM2 | 1.33752193 |
| 41 | WNK3 | 1.33625462 |
| 42 | NUAK1 | 1.33096466 |
| 43 | LIMK1 | 1.30906379 |
| 44 | TNIK | 1.30431202 |
| 45 | GRK7 | 1.29666351 |
| 46 | SRPK1 | 1.28004403 |
| 47 | MAP3K14 | 1.27564952 |
| 48 | IRAK1 | 1.27125638 |
| 49 | PIK3CA | 1.23508156 |
| 50 | CAMK2B | 1.20195538 |
| 51 | TESK1 | 1.18288753 |
| 52 | CSNK1G2 | 1.17172584 |
| 53 | BLK | 1.15512181 |
| 54 | ZAK | 1.09101933 |
| 55 | IRAK2 | 1.08735856 |
| 56 | PLK3 | 1.07258273 |
| 57 | TLK1 | 1.05995424 |
| 58 | DAPK3 | 1.00519594 |
| 59 | TEC | 0.98164537 |
| 60 | GRK1 | 0.97209801 |
| 61 | CAMK2D | 0.95970742 |
| 62 | CDK19 | 0.95839488 |
| 63 | SCYL2 | 0.94139219 |
| 64 | PAK4 | 0.94090599 |
| 65 | CAMK2G | 0.93122555 |
| 66 | OBSCN | 0.90648638 |
| 67 | MAP2K7 | 0.88512175 |
| 68 | ARAF | 0.85432178 |
| 69 | CDK3 | 0.84080556 |
| 70 | SIK3 | 0.83159104 |
| 71 | NEK9 | 0.82810844 |
| 72 | WEE1 | 0.78502601 |
| 73 | IKBKE | 0.78303660 |
| 74 | MUSK | 0.78029160 |
| 75 | NEK6 | 0.77400752 |
| 76 | MAP3K5 | 0.77265326 |
| 77 | PRKCE | 0.75464978 |
| 78 | YES1 | 0.74486904 |
| 79 | ZAP70 | 0.72861552 |
| 80 | NLK | 0.72351291 |
| 81 | TBK1 | 0.72195064 |
| 82 | PASK | 0.71466771 |
| 83 | ABL2 | 0.71209775 |
| 84 | PLK1 | 0.70505971 |
| 85 | PAK1 | 0.70466752 |
| 86 | ADRBK1 | 0.69452184 |
| 87 | ILK | 0.69313341 |
| 88 | AURKA | 0.69010919 |
| 89 | DYRK2 | 0.67200204 |
| 90 | PRKG2 | 0.66415594 |
| 91 | LYN | 0.65814154 |
| 92 | EPHB2 | 0.65212660 |
| 93 | RIPK4 | 0.64252697 |
| 94 | TSSK6 | 0.63467955 |
| 95 | DAPK1 | 0.63368240 |
| 96 | RPS6KA5 | 0.63182858 |
| 97 | PLK2 | 0.62624807 |
| 98 | EIF2AK2 | 0.62256417 |
| 99 | CAMK2A | 0.62152108 |
| 100 | BRAF | 0.60370685 |
| 101 | FRK | 0.60220753 |
| 102 | CAMKK2 | 0.60170606 |
| 103 | NEK2 | 0.58324351 |
| 104 | GRK5 | 0.58143808 |
| 105 | EPHA3 | 0.57907012 |
| 106 | ACVR1B | 0.57309506 |
| 107 | PNCK | 0.55371875 |
| 108 | PRKCG | 0.54864919 |
| 109 | EPHA4 | 0.54532875 |
| 110 | CCNB1 | 0.54311957 |
| 111 | CSNK1G3 | 0.51842299 |
| 112 | TYK2 | 0.51054513 |
| 113 | PRKCQ | 0.50861090 |
| 114 | IKBKB | 0.50048807 |
| 115 | PLK4 | 0.46586575 |
| 116 | SYK | 0.46489529 |
| 117 | MAP2K2 | 0.46368735 |
| 118 | AKT3 | 0.46157790 |
| 119 | PRKACA | 0.45815640 |
| 120 | CSNK2A2 | 0.43123085 |
| 121 | PRKCD | 0.42330766 |
| 122 | CDK8 | 0.41010147 |
| 123 | CSNK2A1 | 0.40957691 |
| 124 | PKN1 | 0.40651340 |
| 125 | PRKCI | 0.39791000 |
| 126 | EPHB1 | 0.39508634 |
| 127 | CSNK1A1 | 0.39466189 |
| 128 | ITK | 0.39359183 |
| 129 | CSK | 0.38817398 |
| 130 | PRKCA | 0.38683722 |
| 131 | FGR | 0.38514620 |
| 132 | AURKB | 0.38287715 |
| 133 | EPHA2 | 0.38042075 |
| 134 | DAPK2 | 0.37558518 |
| 135 | MAP2K6 | 0.36497148 |
| 136 | MAPKAPK3 | 0.35514512 |
| 137 | MAP3K9 | 0.34527382 |
| 138 | CDC7 | 0.33268291 |
| 139 | STK4 | 0.30191337 |
| 140 | CLK1 | 0.28548849 |
| 141 | MAP3K1 | 0.28147805 |
| 142 | CDK14 | 0.28033891 |
| 143 | TTK | 0.26729876 |
| 144 | TAOK2 | 0.26522730 |
| 145 | STK10 | 0.26382748 |
| 146 | ATR | 0.24974569 |
| 147 | TGFBR1 | 0.24954237 |
| 148 | BRSK1 | 0.24688581 |
| 149 | MAP2K4 | 0.24529977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.77054952 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.80959505 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.79543663 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.28465102 |
| 5 | Alzheimers disease_Homo sapiens_hsa05010 | 2.89186070 |
| 6 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.77501301 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.68924826 |
| 8 | Huntingtons disease_Homo sapiens_hsa05016 | 2.59422843 |
| 9 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.37687908 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.34078850 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.15647971 |
| 12 | Ribosome_Homo sapiens_hsa03010 | 2.02130637 |
| 13 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.01823627 |
| 14 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.93426101 |
| 15 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.88445684 |
| 16 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.79587137 |
| 17 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.70907158 |
| 18 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.65997989 |
| 19 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.51878330 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.51742442 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50626357 |
| 22 | Peroxisome_Homo sapiens_hsa04146 | 1.49083026 |
| 23 | RNA polymerase_Homo sapiens_hsa03020 | 1.47831784 |
| 24 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.47766701 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.46379484 |
| 26 | Homologous recombination_Homo sapiens_hsa03440 | 1.45934898 |
| 27 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.43790564 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.41880044 |
| 29 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.41210479 |
| 30 | DNA replication_Homo sapiens_hsa03030 | 1.41115077 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.36368957 |
| 32 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34328459 |
| 33 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.33377095 |
| 34 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.31874673 |
| 35 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.25990845 |
| 36 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.25255150 |
| 37 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.22966662 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22583728 |
| 39 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21409643 |
| 40 | Base excision repair_Homo sapiens_hsa03410 | 1.20998503 |
| 41 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.18769581 |
| 42 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.16752176 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16485732 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14073160 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12223657 |
| 46 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.08634354 |
| 47 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04524074 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.04205879 |
| 49 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03524317 |
| 50 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.99871667 |
| 51 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99426899 |
| 52 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.98098049 |
| 53 | RNA transport_Homo sapiens_hsa03013 | 0.97614894 |
| 54 | Spliceosome_Homo sapiens_hsa03040 | 0.97363030 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 0.97015482 |
| 56 | Metabolic pathways_Homo sapiens_hsa01100 | 0.96217587 |
| 57 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.94344259 |
| 58 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.93942339 |
| 59 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.91773988 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.91190415 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.89507714 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.78451106 |
| 63 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.76098299 |
| 64 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.75980323 |
| 65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75754844 |
| 66 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.75459693 |
| 67 | Retinol metabolism_Homo sapiens_hsa00830 | 0.74474496 |
| 68 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.73573004 |
| 69 | Legionellosis_Homo sapiens_hsa05134 | 0.72787524 |
| 70 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.72393635 |
| 71 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71819135 |
| 72 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71089134 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.70941772 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.69920371 |
| 75 | Phagosome_Homo sapiens_hsa04145 | 0.66677217 |
| 76 | Allograft rejection_Homo sapiens_hsa05330 | 0.64901303 |
| 77 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.64797543 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.64384145 |
| 79 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.63507503 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.62606155 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.58858419 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.58355864 |
| 83 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57346440 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.56712245 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55595910 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55285461 |
| 87 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54325782 |
| 88 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.54103651 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53090250 |
| 90 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51902554 |
| 91 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51344201 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.49374646 |
| 93 | Basal transcription factors_Homo sapiens_hsa03022 | 0.49092080 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.48507223 |
| 95 | ABC transporters_Homo sapiens_hsa02010 | 0.47969580 |
| 96 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47671599 |
| 97 | Sulfur relay system_Homo sapiens_hsa04122 | 0.47104806 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46811850 |
| 99 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46197389 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.46088351 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.45986594 |
| 102 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44951982 |
| 103 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.44420218 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44326199 |
| 105 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.43928596 |
| 106 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.43455681 |
| 107 | Phototransduction_Homo sapiens_hsa04744 | 0.43428095 |
| 108 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.41915585 |
| 109 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40327556 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39889173 |
| 111 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.38519209 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37921136 |
| 113 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37682658 |
| 114 | Malaria_Homo sapiens_hsa05144 | 0.37129896 |
| 115 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.35673693 |
| 116 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.35318674 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.35259383 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35120405 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32866889 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.31128364 |
| 121 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.30714529 |
| 122 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.27770849 |
| 123 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27017063 |
| 124 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.26974569 |
| 125 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.26781109 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.26625385 |
| 127 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26085092 |
| 128 | Asthma_Homo sapiens_hsa05310 | 0.25209496 |
| 129 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.25128489 |
| 130 | Shigellosis_Homo sapiens_hsa05131 | 0.24763370 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.24324274 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.23648246 |
| 133 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22931672 |

